Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Diseases of the Colon and Rectum|March 13, 2024
Systematic Review of Neoadjuvant Immunotherapy for Mismatch Repair Deficient Locally Advanced Colon Cancer: An Emerging StrategyAnthony Loria, Allison M Ammann, Olugbenga O Olowokure, et al.Anti-Cancer Drugs|May 29, 2015
Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignanciesOlivier Rixe, Igor Puzanov, Patricia M LoRusso, et al.The Oncologist|October 25, 2018
A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular CarcinomaGhassan K Abou-Alfa, Rebecca A Miksad, Mohamedtaki A Tejani, et al.Surgery|October 17, 2017
Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteriaYoung Kim, Christopher C Stahl, Abouelmagd Makramalla, et al.Journal of Surgical Oncology|January 21, 2017
Does radiologic response correlate to pathologic response in patients undergoing neoadjuvant therapy for borderline resectable pancreatic malignancy?Brent T Xia, Baojin Fu, Jiang Wang, et al.Cancer|June 16, 2018
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancerHanna K Sanoff, Richard M Goldberg, Anastasia Ivanova, et al.Pageof 1